김진국 (KAIST 의과학대학원)님 | 한빛사연구자 > 한빛사

KAIST 의과학대학원

최종업데이트 2023.07.17.

Therapeutic Gfral silencing via antisense oligonucleotides ameliorates cancer-associated cachexia and extends survival in tumor-bearing mice
- Cell Rep. Med., July 27, 2026 | https://doi.org/10.1016/j.xcrm.2026.102939
- 2026-07
- 의약학
- 한빛사논문
A framework for individualized splice-switching oligonucleotide therapy
- Nature, 12 July 2023 | https://doi.org/10.1038/s41586-023-06277-0
- 2023-07
- 의약학
- 한빛사논문
- 김진국(Harvard Medical School)
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
- N. Engl. J. Med., October 24, 2019; 381:1644-1652 | DOI: 10.1056/NEJMoa1813279
- 2019-10
- 한빛사논문
Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ
- Cell Reports, Volume 3, Issue 1, 31 January 2013, Pages 260-273 | https://doi.org/10.1016/j.celrep.2012.12.013
- 2013-01
- 의약학
- 상위피인용논문
Spatiotemporal Evolution of the Primary Glioblastoma Genome
- Cancer Cell, Volume 28, Issue 3, p318–328, 14 September 2015 | DOI: http://dx.doi.org/10.1016/j.ccell.2015.07.013
- 2015-09
- 의약학
- 한빛사논문, 상위피인용논문
- 김진국(Massachusetts Institute of Technology)
Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression
- Nat. Biotechnol., Published online: 26 April 2009 | doi:10.1038/nbt.1540
- 2009-04
- 한빛사논문

연구자 ID

저자논문